MSE
EW icon

MUFG Securities EMEA’s Edwards Lifesciences EW Stock Holding History

MUFG Securities EMEA’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Sell
22,537
-1,253
-5% -$105K 0.02% 327
2026
Q1 		$1.91M Hold
23,790
– – 0.03% 294
2025
Q4 		$2.03M Buy
23,790
+12,553
+112% +$1.03M 0.02% 304
2025
Q3 		$874K Buy
11,237
+9,499
+547% +$742K 0.02% 271
2025
Q2 		$136K Buy
+1,738
New +$130K 0.01% 264
2024
Q4 		– Sell
-125,000
Closed -$8.25M – 200
2024
Q3 		$8.25M Buy
+125,000
New +$9.08M 0.3% 95
2022
Q4 		– Sell
-90,000
Closed -$7.44M – 165
2022
Q3 		$7.44M Buy
+90,000
New +$8.66M 0.14% 36
2022
Q2 		– Sell
-10,400
Closed -$1.22M – 145
2022
Q1 		$1.22M Hold
10,400
– – 0.02% 83
2021
Q4 		$1.35M Sell
10,400
-28,000
-73% -$3.27M 0.02% 116
2021
Q3 		$4.35M Sell
38,400
-113,200
-75% -$12.9M 0.05% 152
2021
Q2 		$15.7M Sell
151,600
-97,000
-39% -$9.14M 0.15% 94
2021
Q1 		$20.8M Sell
248,600
-193,000
-44% -$16.3M 0.17% 108
2020
Q4 		$40.3M Sell
441,600
-140,720
-24% -$11.7M 0.31% 63
2020
Q3 		$46.5M Buy
582,320
+290,720
+100% +$22.7M 0.44% 39
2020
Q2 		$20.2M Sell
291,600
-341,100
-54% -$24.2M 0.18% 104
2020
Q1 		$39.8M Buy
632,700
+617,700
+4,118% +$44.5M 0.4% 47
2019
Q4 		$1.17M Sell
15,000
-145,800
-91% -$11.4M 0.01% 420
2019
Q3 		$11.8M Buy
+160,800
New +$11.3M 0.14% 110
2018
Q4 		– Sell
-233,328
Closed -$13.5M – 514
2018
Q3 		$13.5M Buy
233,328
+232,620
+32,856% +$11.4M 0.19% 88
2018
Q2 		$34K Buy
+708
New +$33K ﹤0.01% 336
2018
Q1 		– Sell
-60,000
Closed -$2.25M – 202
2017
Q4 		$2.25M Buy
+60,000
New +$2.2M 0.05% 122

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

MUFG Securities EMEA's EW Position: Q2 2026 in Review

MUFG Securities EMEA reduced its Edwards Lifesciences (EW) stake by 5.3% in Q2 2026, selling an estimated $105K and leaving 22,537 shares worth $2.04M. The position accounts for 0.02% of the portfolio, ranked #327.

MUFG Securities EMEA first reported a position in EW in Q4 2017 and has held it in 21 quarters since. The position peaked at $46.5M in Q3 2020. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • MUFG Securities EMEA held 22,537 shares of Edwards Lifesciences worth $2.04M as of Q2 2026.
  • MUFG Securities EMEA sold 1,253 Edwards Lifesciences shares in Q2 2026, an estimated $105K.
  • Edwards Lifesciences made up 0.02% of MUFG Securities EMEA's portfolio in Q2 2026, its #327 holding.
  • MUFG Securities EMEA first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 21 quarters since.
  • MUFG Securities EMEA's Edwards Lifesciences position peaked at $46.5M in Q3 2020.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.